Kyoto University

NTT Research and Harvard Collaborate on Cardiovascular Bio Digital Twin

Retrieved on: 
Wednesday, November 16, 2022

NTT Research scientists will work with the Disease Biophysics Group (DBG) at SEAS to engineer a model of the human heart, elucidate fundamental laws of muscular pumps, and apply lessons learned to a cardiovascular (CV) bio digital twin model.

Key Points: 
  • NTT Research scientists will work with the Disease Biophysics Group (DBG) at SEAS to engineer a model of the human heart, elucidate fundamental laws of muscular pumps, and apply lessons learned to a cardiovascular (CV) bio digital twin model.
  • His groups long-term goal of engineering a living, functional heart maps well with our CV bio digital twin initiative.
  • I am honored to be joining the MEI Lab team at NTT Research while continuing complementary work at Harvard, Mr. Ishii said.
  • NTT Research is part of NTT, a global technology and business solutions provider with an annual R&D budget of $3.6 billion.

NOSTER launches Metabolome Analysis Service of metabolites produced by gut microbiota and announces the recipients of the 2022 NOSTER & Science Microbiome Prize

Retrieved on: 
Monday, July 25, 2022

Noster also announced the recipients of the 2022 'NOSTER & Science Microbiome Prize'established by Noster Inc with the American Association for the Advancement of Science (AAAS) publisher of the journal Science.

Key Points: 
  • Noster also announced the recipients of the 2022 'NOSTER & Science Microbiome Prize'established by Noster Inc with the American Association for the Advancement of Science (AAAS) publisher of the journal Science.
  • Based on these findings Noster has built a comprehensive library of original lipid metabolites produced by gut microbiota.
  • Noster makes full use of this technology to provide state of the art 'Metabolome Analysis Service' for exploring the properties of the still unexplored world of gut microbial metabolites.
  • In addition to 'Metabolome Analysis Service', we also provide an 'Gut Microbiota Analysis Service', which can be used in combination to clarify the correlation between gut microbiota and metabolites.

NOSTER launches Metabolome Analysis Service of metabolites produced by gut microbiota and announces the recipients of the 2022 NOSTER & Science Microbiome Prize

Retrieved on: 
Monday, July 25, 2022

Noster also announced the recipients of the 2022 'NOSTER & Science Microbiome Prize'established by Noster Inc with the American Association for the Advancement of Science (AAAS) publisher of the journal Science.

Key Points: 
  • Noster also announced the recipients of the 2022 'NOSTER & Science Microbiome Prize'established by Noster Inc with the American Association for the Advancement of Science (AAAS) publisher of the journal Science.
  • Based on these findings Noster has built a comprehensive library of original lipid metabolites produced by gut microbiota.
  • Noster makes full use of this technology to provide state of the art 'Metabolome Analysis Service' for exploring the properties of the still unexplored world of gut microbial metabolites.
  • In addition to 'Metabolome Analysis Service', we also provide an 'Gut Microbiota Analysis Service', which can be used in combination to clarify the correlation between gut microbiota and metabolites.

NOSTER launches Metabolome Analysis Service of metabolites produced by gut microbiota and announces the recipients of the 2022 NOSTER & Science Microbiome Prize

Retrieved on: 
Monday, July 25, 2022

Noster also announced the recipients of the 2022 'NOSTER & Science Microbiome Prize'established by Noster Inc with the American Association for the Advancement of Science (AAAS) publisher of the journal Science.

Key Points: 
  • Noster also announced the recipients of the 2022 'NOSTER & Science Microbiome Prize'established by Noster Inc with the American Association for the Advancement of Science (AAAS) publisher of the journal Science.
  • Based on these findings Noster has built a comprehensive library of original lipid metabolites produced by gut microbiota.
  • Noster makes full use of this technology to provide state of the art 'Metabolome Analysis Service' for exploring the properties of the still unexplored world of gut microbial metabolites.
  • In addition to 'Metabolome Analysis Service', we also provide an 'Gut Microbiota Analysis Service', which can be used in combination to clarify the correlation between gut microbiota and metabolites.

World-first Integrated Testing Facility for Fusion Power Plant Equipment to be Constructed in Japan

Retrieved on: 
Wednesday, July 6, 2022

A world first, this facility, named UNITY: Unique Integrated Testing Facility, is on a path to demonstrate electricity generation using fusion relevant technologies in 2024.

Key Points: 
  • A world first, this facility, named UNITY: Unique Integrated Testing Facility, is on a path to demonstrate electricity generation using fusion relevant technologies in 2024.
  • UNITY has a pioneering design that can test both the heat extraction and fuel cycle systems required for fusion power plants in a single facility.
  • To further strengthen our position in the fusion engineering domain, KF has decided to construct UNITY, the world's first integrated testing facility for fusion power plant components.
  • UNITY will enable integrated testing of a suite of energy conversion equipment in a fusion power plant without the use of nuclear reactions by engineeringly simulating the thermal and magnetic environment within a fusion power core.

2022 Blue Planet Prize: Announcement of Prize Winners - THE ASAHI GLASS FOUNDATION

Retrieved on: 
Wednesday, June 15, 2022

This year marks the 31st awarding of the Blue Planet Prize, the international environmental award sponsored by the Asahi Glass Foundation, chaired by Takuya Shimamura.

Key Points: 
  • This year marks the 31st awarding of the Blue Planet Prize, the international environmental award sponsored by the Asahi Glass Foundation, chaired by Takuya Shimamura.
  • Every year, the Foundation selects two winners, individuals or organizations who have made significant contributions to the resolution of global environmental problems.
  • The Board of Directors have selected the following 2022 Blue Planet Prize recipients.
  • This press release and the photo of each recipient will be published 11 a.m. on Wednesday June 15 on the website of the Asahi Glass Foundation ( www.af-info.or.jp/en ).

OPPO Launches 2022 Renovators Emerging Artists Project, Empowering Young Artists Worldwide to Innovate Through Art and Technology

Retrieved on: 
Wednesday, June 8, 2022

To date, nearly ten thousand artists have participated in the program and several outstanding projects have been further developed with OPPO's support.

Key Points: 
  • To date, nearly ten thousand artists have participated in the program and several outstanding projects have been further developed with OPPO's support.
  • William Liu, Vice President and President of Global Marketing at OPPO, and the initiator of the Renovators program, said: "Through the OPPO Renovators, we aim to build a global platform for future-oriented art and design practices.
  • Renovators 2022 continues its focus on the concept of "Art + Tech" by inviting artists from all over the world to submit their artwork under two contest categories - Future Renovators and Brand Renovators.
  • Beyond devices, OPPO also provides its users with ColorOS operating system and internet services such as OPPO Cloud and OPPO+.

Altos Labs Announces Sponsored Research Agreement with Kyoto University's CiRA to Foster Cellular Rejuvenation Programming Research

Retrieved on: 
Thursday, June 2, 2022

SAN FRANCISCO, June 2, 2022 /PRNewswire/ -- Altos Labs (Altos) today announced that it has signed a sponsored research agreement with the Center for iPS Cell Research and Application (CiRA) at Japan's Kyoto University. Effective May 1 of this year, Altos has committed to fund four CiRA research projects for five years to investigate aspects of cellular rejuvenation programming.

Key Points: 
  • SAN FRANCISCO, June 2, 2022 /PRNewswire/ -- Altos Labs (Altos) today announced that it has signed a sponsored research agreement with the Center for iPS Cell Research and Application (CiRA) at Japan's Kyoto University.
  • Effective May 1 of this year, Altos has committed to fund four CiRA research projects for five years to investigate aspects of cellular rejuvenation programming.
  • "Altos is deeply committed to a long-term research effort that will identify the foundational biological mechanisms of cellular rejuvenation programming.
  • Under the sponsored research agreement, projects are supervised by Altos Senior Scientific Advisor Shinya Yamanaka, who is also Professor and Director Emeritus at CiRA.

I Peace accelerates allogeneic iPSC-derived cell therapies with g high throughput method to identify a large number of donors with specific HLA haplotypes.

Retrieved on: 
Wednesday, May 11, 2022

With this high-throughput method, the company has already succeeded in identifying 1,547 HLA-homozygous potential donors and has already generated iPSCs.

Key Points: 
  • With this high-throughput method, the company has already succeeded in identifying 1,547 HLA-homozygous potential donors and has already generated iPSCs.
  • Unlike conventional methods of identifying specific potential donors that yield only a handful of matches at best, this process can help identify a large number of potential donors with high efficiency.
  • We sequenced 98 HLA loci by high-resolution, next-generation sequencing-based HLA haplotyping from seven people, and found that the algorithm accuracy was above 93%.
  • I Peace's mission is to ease the suffering of diseased patients and help healthy people maintain a high quality of life.

Joint Research Shows that DENSO's Microalga, Coccomyxa sp. KJ Has Virucidal Effect against COVID-19

Retrieved on: 
Thursday, March 24, 2022

KJ breaks the envelope membranes(3) of herpesviruses and has a virucidal effect against the viruses.

Key Points: 
  • KJ breaks the envelope membranes(3) of herpesviruses and has a virucidal effect against the viruses.
  • The group will also research whether this microalga MGDG has a virucidal effect against influenza viruses, human coronaviruses, and other viruses with envelope membranes other than herpesviruses and COVID-19.
  • The results of the research may lead to the development of products that effectively counter COVID-19 and other viruses.
  • "Stories," one of the DENSO-owned media, also features the plant: bit.ly/3JDGt38
    (2) Virucidal effect means destroying the ability of viruses to infect cells.